Communiqués

25/08/22 Not What The Doctor Ordered: Authorisation Application Withdrawn For Pharma Patent Settlement In Australia AQ
29/07/22 Authorisation request for proposed settlement between pharmaceutical companies withdrawn AQ
04/08/21 Celgene : Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid®) AQ
09/07/21 Besra Gold Inc: Announces Lodgment of Replacement Prospectus & Adjournment of Note Holder Meeting NE
14/04/21 Celgene : Rocket docket pharma patent litigation taking off in Australia and other emerging trends AQ
07/04/21 DGAP-WpÜG: Tender Offer / Target company: ; Bidder: qqqqq EQ
25/03/21 Leonteq becomes new issuer on BX Swiss – “deriBX” TE
07/07/20 BX Swiss AG receives approval from FINMA as Swiss Client Advisor Register TE
03/07/20 Celgene : Parts Of Amended Patented Medicines Regulations Related To The PMPRB Struck Down AQ
03/07/20 Furniture company mömax will be the new anchor tenant in the Rüti Center in Pratteln TE
29/06/20 Celgene V. Sun Pharma Global: Satisfying Subject Matter Jurisdiction Under § 271(e)(2) AQ
18/06/20 BX Swiss AG uses Blockchain technology to protect approved securities prospectuses against falsification TE
28/05/20 BX Swiss AG receives approval from FINMA as a Prospectus Review Office TE
22/11/19 Celgene : Announces Plans to Transfer Listing of Celgene's Contingent Value Rights Following Closing of Acquisition by Bristol-Myers Squibb AQ
22/11/19 Celgene : BONNEY MICHAEL W PU
22/11/19 Celgene : CASEY MICHAEL D PU
22/11/19 Celgene : FRIEDMAN MICHAEL A PU
22/11/19 Celgene : COX CARRIE SMITH PU
22/11/19 Celgene : LOUGHLIN JAMES J PU
22/11/19 Celgene : HALLER JULIA A PU
22/11/19 Celgene : REICIN ALISE PU
22/11/19 Celgene : CURRAN TERRIE PU
22/11/19 Celgene : BILLER JONATHAN PU
22/11/19 Celgene : ALLES MARK J PU
22/11/19 Celgene : ELKINS DAVID V PU
Aucun résultat pour cette recherche
🔇